4//SEC Filing
MULROY DENNIS 4
Accession 0001415889-25-001044
CIK 0001370053other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 5:32 PM ET
Size
19.6 KB
Accession
0001415889-25-001044
Insider Transaction Report
Form 4
ANAPTYSBIO, INCANAB
MULROY DENNIS
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-01-06+5,245→ 15,856 total - Exercise/Conversion
Restricted Stock Unit
2025-01-03−8,293→ 24,877 total→ Common Stock (8,293 underlying) - Exercise/Conversion
Common Stock
2025-01-03+8,293→ 14,018 total - Tax Payment
Common Stock
2025-01-06$15.30/sh−2,054$31,426→ 13,802 total - Exercise/Conversion
Restricted Stock Unit
2025-01-06−5,245→ 10,490 total→ Common Stock (5,245 underlying) - Award
Restricted Stock Unit
2025-01-07+26,800→ 26,800 total→ Common Stock (26,800 underlying) - Award
Stock Option (right to buy)
2025-01-07+76,400→ 76,400 totalExercise: $14.83Exp: 2035-01-06→ Common Stock (76,400 underlying) - Tax Payment
Common Stock
2025-01-03$14.60/sh−3,407$49,742→ 10,611 total
Footnotes (8)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]Reflects the acquisition of 981 shares acquired under the Company's ESPP.
- [F3]Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation.
- [F4]The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.
- [F5]The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F6]The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F7]The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F8]The stock option vests as to 25% of the total shares on January 7, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
ANAPTYSBIO, INC
CIK 0001370053
Entity typeother
Related Parties
1- filerCIK 0001276840
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 5:32 PM ET
- Size
- 19.6 KB